Biocon Biologics: FDA Approves YESAFILI As First Interchangeable Biological Product To Eylea
(RTTNews) - Biocon Biologics, a subsidiary of Biocon Ltd, announced the FDA has approved the company's first-to-file application for Yesafili, an ...
Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Biocon Biologics, a subsidiary of Biocon Ltd, announced the FDA has approved the company's first-to-file application for Yesafili, an ...
The Nifty Pharma index was trading 0.05 per cent up at 19004.75.
An analyst from YES Securities said Infosys has displayed a bearish sentiment evidenced by its breakdown from the rising channel pattern observed on the weekly chart.
The Nifty Pharma index was trading 0.03 per cent up at 18891.6.
The global type 1 diabetes market size is calculated at USD 15.95 billion in 2024 and is expected to be worth around USD 24.36 billion by 2031, growing at...